Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucose Intolerance | 6 | 2019 | 100 | 2.780 |
Why?
|
| Blood Glucose | 11 | 2021 | 867 | 2.670 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2025 | 1229 | 2.370 |
Why?
|
| Insulin Resistance | 8 | 2019 | 379 | 1.940 |
Why?
|
| Insulin-Secreting Cells | 6 | 2019 | 441 | 1.460 |
Why?
|
| Insulin | 8 | 2019 | 1185 | 1.100 |
Why?
|
| Metformin | 5 | 2025 | 125 | 1.050 |
Why?
|
| Hypoglycemic Agents | 4 | 2019 | 379 | 0.950 |
Why?
|
| Glucose Clamp Technique | 3 | 2019 | 42 | 0.810 |
Why?
|
| Prediabetic State | 4 | 2025 | 42 | 0.760 |
Why?
|
| Glucose Tolerance Test | 7 | 2019 | 232 | 0.760 |
Why?
|
| C-Peptide | 6 | 2019 | 184 | 0.730 |
Why?
|
| Exercise Therapy | 1 | 2019 | 94 | 0.570 |
Why?
|
| Exercise | 2 | 2025 | 353 | 0.510 |
Why?
|
| Obesity | 3 | 2019 | 1018 | 0.490 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 701 | 0.430 |
Why?
|
| Aging | 1 | 2019 | 727 | 0.430 |
Why?
|
| Fasting | 3 | 2019 | 163 | 0.410 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 754 | 0.370 |
Why?
|
| Insulin Glargine | 3 | 2019 | 12 | 0.370 |
Why?
|
| Child | 6 | 2019 | 7355 | 0.320 |
Why?
|
| Adipogenesis | 2 | 2007 | 41 | 0.310 |
Why?
|
| Young Adult | 6 | 2019 | 6930 | 0.300 |
Why?
|
| Adolescent | 6 | 2019 | 9606 | 0.290 |
Why?
|
| Middle Aged | 11 | 2025 | 27573 | 0.280 |
Why?
|
| PPAR gamma | 2 | 2005 | 75 | 0.260 |
Why?
|
| Male | 15 | 2025 | 44557 | 0.260 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2021 | 219 | 0.260 |
Why?
|
| Adult | 10 | 2025 | 27918 | 0.260 |
Why?
|
| Liraglutide | 2 | 2019 | 8 | 0.250 |
Why?
|
| Female | 15 | 2025 | 48702 | 0.250 |
Why?
|
| Arginine | 2 | 2019 | 141 | 0.240 |
Why?
|
| Lipid Metabolism | 1 | 2007 | 214 | 0.230 |
Why?
|
| Sleep | 2 | 2019 | 448 | 0.220 |
Why?
|
| Adipocytes | 4 | 2007 | 169 | 0.220 |
Why?
|
| Response Elements | 1 | 2004 | 65 | 0.210 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 759 | 0.210 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 290 | 0.200 |
Why?
|
| Humans | 15 | 2025 | 93515 | 0.170 |
Why?
|
| Selenium Compounds | 1 | 2000 | 3 | 0.160 |
Why?
|
| Food, Formulated | 1 | 2000 | 25 | 0.160 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 1847 | 0.150 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2019 | 4 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2000 | 131 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 32 | 0.150 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2019 | 53 | 0.140 |
Why?
|
| Withholding Treatment | 1 | 2019 | 121 | 0.140 |
Why?
|
| Aged | 5 | 2025 | 20434 | 0.140 |
Why?
|
| Medication Adherence | 1 | 2019 | 122 | 0.140 |
Why?
|
| Body Weight | 1 | 2019 | 449 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2000 | 350 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2019 | 3054 | 0.120 |
Why?
|
| Age Factors | 1 | 2018 | 1906 | 0.100 |
Why?
|
| Time Factors | 2 | 2019 | 5410 | 0.100 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2013 | 59 | 0.100 |
Why?
|
| Gastroplasty | 1 | 2013 | 27 | 0.100 |
Why?
|
| Risk Factors | 2 | 2025 | 5899 | 0.100 |
Why?
|
| Glucose | 3 | 2021 | 692 | 0.090 |
Why?
|
| 3T3-L1 Cells | 3 | 2007 | 35 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2013 | 181 | 0.090 |
Why?
|
| Mice | 8 | 2008 | 12269 | 0.080 |
Why?
|
| Neoplasms | 1 | 2025 | 3169 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 740 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 87 | 0.070 |
Why?
|
| Teratoma | 1 | 2008 | 58 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 309 | 0.070 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2007 | 3 | 0.060 |
Why?
|
| Pyruvic Acid | 1 | 2007 | 12 | 0.060 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 155 | 0.060 |
Why?
|
| Triglycerides | 1 | 2007 | 231 | 0.060 |
Why?
|
| Collagen Type VI | 1 | 2005 | 4 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 962 | 0.060 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2004 | 4 | 0.060 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2004 | 8 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2005 | 439 | 0.060 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 38 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2004 | 65 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2005 | 58 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2007 | 299 | 0.050 |
Why?
|
| Dimerization | 1 | 2004 | 148 | 0.050 |
Why?
|
| Animals | 8 | 2008 | 28155 | 0.050 |
Why?
|
| Gluconeogenesis | 1 | 2004 | 15 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2004 | 192 | 0.050 |
Why?
|
| Life Style | 1 | 2025 | 183 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 2910 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 880 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 729 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2007 | 1621 | 0.050 |
Why?
|
| Gene Expression | 1 | 2007 | 1301 | 0.050 |
Why?
|
| Diet | 1 | 2025 | 460 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 1133 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2005 | 443 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2012 | 0.040 |
Why?
|
| Protein Binding | 1 | 2004 | 1534 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 1117 | 0.040 |
Why?
|
| Selenic Acid | 1 | 2000 | 1 | 0.040 |
Why?
|
| Sodium Selenite | 1 | 2000 | 2 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2000 | 24 | 0.040 |
Why?
|
| Selenium | 1 | 2000 | 46 | 0.040 |
Why?
|
| Energy Intake | 1 | 2000 | 97 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2000 | 159 | 0.040 |
Why?
|
| Jet Lag Syndrome | 1 | 2019 | 13 | 0.040 |
Why?
|
| Liver | 1 | 2004 | 1210 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 1234 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2000 | 239 | 0.040 |
Why?
|
| Overweight | 1 | 2019 | 120 | 0.030 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 124 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 328 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 285 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2000 | 429 | 0.030 |
Why?
|
| Ligands | 2 | 2008 | 476 | 0.030 |
Why?
|
| RNA Interference | 2 | 2007 | 379 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2008 | 1587 | 0.020 |
Why?
|
| United States | 1 | 2025 | 7622 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2000 | 4560 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2802 | 0.020 |
Why?
|
| Estrogen Receptor beta | 1 | 2008 | 26 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 439 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2008 | 135 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2008 | 149 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 2008 | 119 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2008 | 81 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 587 | 0.020 |
Why?
|
| Estradiol | 1 | 2008 | 247 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 331 | 0.020 |
Why?
|
| Uterus | 1 | 2008 | 227 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 894 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 216 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2008 | 270 | 0.010 |
Why?
|
| Polyomavirus | 1 | 2005 | 16 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2005 | 24 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 2008 | 227 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 85 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 26 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2007 | 362 | 0.010 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 77 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 16 | 0.010 |
Why?
|
| Gluconates | 1 | 2004 | 14 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 730 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2005 | 158 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 2004 | 39 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 64 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 223 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2004 | 276 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2004 | 129 | 0.010 |
Why?
|
| beta Catenin | 1 | 2005 | 265 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 1866 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 555 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 2755 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 1133 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2495 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 3435 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 1173 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1799 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 557 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2850 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 3502 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1985 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 4272 | 0.010 |
Why?
|